Rituximab exerts a dual effect in pemphigus vulgaris (Q81478296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Rituximab exerts a dual effect in pemphigus vulgaris (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1 reference

pemphigus vulgaris

1 reference

Rüdiger Eming

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Angela Nagel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sonja Wolff-Franke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Eva Podstawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Dirk Debus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Michael Hertl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

19 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2850-2858

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563178%20AND%20SRC:MED&resulttype=core&format=json

Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

T cell control in autoimmune bullous skin disorders

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

A single cycle of rituximab for the treatment of severe pemphigus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Desmosomes and disease: pemphigus and bullous impetigo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Rituximab in refractory autoimmune bullous diseases.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

From T to B and back again: positive feedback in systemic autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021

Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.172

7 January 2021